The Endoscopes Market Size was valued at USD 24.00 Billion in 2023 and is expected to reach USD 36.93 Billion by 2032 and grow at a CAGR of 4.93% over the forecast period 2024-2032. This report points to the increasing prevalence and incidence of endoscopy-requiring diseases, which fuel demand for advanced diagnostic and therapeutic procedures. The research looks into trends in the use of endoscopes by type and by medical specialty, highlighting the trend toward minimally invasive procedures and enhanced procedural efficiency. It also looks into healthcare expenditure on endoscopy procedures by region and by payer, mirroring increased investment in sophisticated medical technologies. The report also emphasizes the advances in technology, such as innovations in high-definition imaging, robotic-assisted endoscopy, and artificial intelligence-based diagnostics, and the growing use of these technologies to improve procedural accuracy and patient outcomes.
Drivers
Rising prevalence of gastrointestinal (GI) disorders, colorectal cancer, and respiratory diseases, increasing the demand for minimally invasive procedures.
As reported by the World Cancer Research Fund, colorectal cancer is one of the most frequent cancers in the world, needing periodic endoscopic screening. The development of AI-aided endoscopy, 4K imaging, and robotic procedures also enhances diagnostic efficiency and accuracy. The application of artificial intelligence in endoscopy has improved polyp detection rates, with fewer chances of misdiagnosis for colorectal cancer screenings. Additionally, the trend towards ambulatory surgical centers and outpatient endoscopy because of cost savings and reduced recovery periods is also driving market growth. The increasing use of disposable endoscopes to avoid cross-contamination and healthcare-associated infections is also a major driver, with leading players such as Ambu A/S and Boston Scientific increasing their single-use endoscope offerings. Further, rising government programs and reimbursement policies favoring endoscopic procedures are promoting increased adoption. For instance, in the U.S., Medicare is reimbursing preventive colonoscopies, which make early detection of colorectal cancer more feasible. Such factors on the whole help in fueling the high demand for advanced endoscopic technologies, pushing innovation and market growth.
Restraints
The high cost of endoscopic procedures and devices remains a significant restraint.
Advanced endoscopic equipment, including robotic and AI-based endoscopes, are expensive to invest in, making them less acceptable for use in emerging healthcare markets. Reprocessing and sterilization of re-usable endoscopes also include high operation expenses and stringent regulatory requirements. The FDA and CDC have released rigorous regulations on the reprocessing of endoscopes to avoid cross-contamination, contributing to the economic costs of healthcare facilities. Further, limited reimbursement policies in some nations restrict patient access to endoscopy procedures. For example, endoscopic diagnostic private insurance coverage is still lacking in some areas, making it non-spread use. The service complexity of keeping endoscopes maintained, from frequent servicing and part replacement to a higher rate of maintenance activities, raises overall cost of ownership, which may discourage small outpatient facilities and clinics from purchasing up-market endoscopy equipment. Furthermore, inadequacy in qualified professionals able to handle upgraded endoscopic machinery slows down the penetration of markets. The reliance on skilled gastroenterologists and surgeons to conduct procedures efficiently means underdeveloped healthcare systems are at a loss to match demand. These operational and cost challenges act as brakes on widespread uptake of endoscopic technology.
Opportunities
The rising adoption of AI-powered and robotic-assisted endoscopy presents a major opportunity for the market.
AI-based endoscopes optimize real-time lesion detection, polyp detection, and automated diagnosis to enhance clinical outcomes. Medtronic's GI Genius AI technology, for instance, has greatly enhanced the rate of polyp detection, resulting in the diagnosis of early-stage colorectal cancer. In addition, increased adoption for single-use endoscopes with infection control advantages presents new opportunities for market growth. With growing concern over hospital-acquired infections, disposable endoscopes obviate the necessity of reprocessing, minimizing the chances of contamination. The rising trend for minimally invasive procedures is yet another opportunity since patients are now opting more and more for outpatient and same-day surgical procedures in place of traditional surgery. Tele-endoscopy and remote diagnosis are also finding favor, facilitating expert consultation over geographies. The growth of healthcare infrastructure in developing economies is further driving demand, with governments stepping up investments in advanced medical equipment. For instance, India's Ayushman Bharat program seeks to enhance the availability of cutting-edge diagnostics, such as endoscopic intervention. The growing use of capsule endoscopy for non-invasive gastroenterology diagnostics, respiratory disease, and detecting internal bleeding is also picking up pace. These technological innovations and changing healthcare trends are poised to generate significant growth prospects in the years to come.
Challenges
The risk of infection transmission and cross-contamination remains one of the biggest challenges in the endoscopes market.
Even with stringent reprocessing protocols, infection reports associated with dirty endoscopes persist, and patient safety is brought into question. In 2019, the CDC reported more than 400 cases of infections due to poorly cleaned duodenoscopes, leading regulatory agencies to advocate for more stringent sterilization procedures. The other significant challenge is the lack of qualified endoscopists and technicians, especially in emerging healthcare markets. Specialized training is needed to perform advanced endoscopic procedures, and insufficient numbers of trained professionals restrict patient access to high-end diagnostics. In addition, regulatory barriers and long approval times for new endoscopic equipment delay market entry for manufacturers. FDA and CE approval criteria for medical devices demand lengthy clinical trials, which delay time-to-market. Data privacy issues related to AI-enabled endoscopy are another challenge. While AI-based endoscopic systems gather and interpret patient data, cybersecurity attacks and data breaches are a looming threat. The heavy price tag of innovation and R&D costs in AI and robotic endoscopy also keeps smaller entrants from competing with established majors such as Olympus and Boston Scientific. Meeting these challenges will be important for long-term market growth.
By Product
In 2023, the reusable endoscopes segment was the market leader in the endoscopes market, accounting for a substantial 83.3% revenue share. The supremacy of reusable endoscopes is largely fueled by their extensive usage in hospitals and specialty clinics on account of cost savings over multiple procedures, enhanced imaging capabilities, and the availability of high-definition visualization technologies. Moreover, well-established reprocessing and sterilization guidelines have bolstered their ongoing popularity among healthcare providers.
The disposable endoscopes market is expected to see the highest growth over the forecast period. Single-use endoscopes are driven by demands for minimizing cross-contamination and hospital-acquired infections (HAIs), strict infection control standards, and their expanding use in outpatient facilities. Their simplicity, lower turnaround time between procedures, and cost savings of preventing reprocessing costs drive their increased market presence.
By End Use
Outpatient facilities was the highest revenue-generating segment in 2023, with a market share of 48.6%. This is because of the increasing demand for minimally invasive procedures in ambulatory surgical centers (ASCs) and diagnostic clinics, which are cost-effective and time-saving options compared to hospital-based procedures. The move towards outpatient endoscopic intervention is also fueled by the increasing patient preference for same-day procedures and the improvements in portable endoscopy systems.
The hospitals segment is expected to post high growth during the forecast period. Rising investments by hospitals in advanced endoscopic technology, growing volumes of complex endoscopic procedures, and adoption of AI-enabled and robot-assisted endoscopy systems are the main growth drivers for this segment. Moreover, hospitals remain the ideal place for high-risk and critical endoscopic procedures, and therefore the demand for endoscopic devices remains consistent within hospitals.
In 2023, North America led the world in the endoscopes market with the highest 36.6% revenue share. The region's leadership is due to the high incidence of gastrointestinal (GI) diseases, colorectal cancer, and other chronic conditions that necessitate endoscopic procedures. The region is also supported by well-developed healthcare infrastructure, sophisticated endoscopic technologies, and a high rate of adoption of minimally invasive procedures. The expanding geriatric population, more susceptible to endoscopic therapy, and supportive reimbursement policies further fuel market growth across the region. Key industry players, coupled with ongoing R&D spending in AI-enabled and robotic endoscopy, further propel technological innovation across North America's endoscopy market.
In contrast, the Asia-Pacific market is estimated to be the fastest-growing market for endoscopes over the forecasting period. The high growth is driven by growing healthcare spending, growing awareness of early disease detection, and an expanding patient base with digestive and respiratory diseases. Moreover, the development of healthcare infrastructure in emerging markets such as China and India, along with the increasing use of disposable endoscopes owing to infection control issues, drives market growth. The growth of medical tourism in nations like Thailand and South Korea also contributes significantly to the increasing demand for endoscopic procedures throughout the region.
Olympus Corporation – EVIS X1, GIF Series, CF Series
Boston Scientific Corporation – SpyGlass DS, EXALT Model D
PENTAX Medical (Hoya Corporation) – i10 Series, J10 Series
FUJIFILM Holdings Corporation – ELUXEO, EG Series, EC Series
Karl Storz GmbH & Co. KG – IMAGE1 S, TELE PACK+
Stryker – 1588 AIM Platform, IDEAL EYES
Medtronic – PillCam, Emprint Ablation Catheter
Ambu A/S – aScope 4, aScope Gastro
STERIS plc – PENTAX Medical ONE Pulmo, EndoStratus
Richard Wolf GmbH – ENDOCAM Logic 4K, ERAGONstitch
In March 2025, Meditech secured a 28 billion won investment to drive innovation in AI-powered electric endoscopes. The company aims to revolutionize the global endoscope market with advanced AI technology and expand its market presence.
In Nov 2024, Valens Semiconductor, a leading provider of high-performance connectivity solutions, announced its plans to showcase groundbreaking innovations at Medica 2024. This includes a new chip designed to power some of the most advanced endoscopes in the industry, enhancing imaging and connectivity in medical applications.
| Report Attributes | Details |
|---|---|
| Market Size in 2023 | USD 24.00 billion |
| Market Size by 2032 | USD 36.93 billion |
| CAGR | CAGR of 4.93% From 2024 to 2032 |
| Base Year | 2023 |
| Forecast Period | 2024-2032 |
| Historical Data | 2020-2022 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Product [Endoscopes (Reusable Endoscopes, Disposable Endoscopes)] • By End Use [Hospitals, Outpatient Facilities] |
| Regional Analysis/Coverage | North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia, Rest of Latin America) |
| Company Profiles | Olympus Corporation, Boston Scientific Corporation, PENTAX Medical (Hoya Corporation), FUJIFILM Holdings Corporation, Karl Storz GmbH & Co. KG, Stryker, Medtronic, Ambu A/S, STERIS plc, Richard Wolf GmbH. |
Ans: The Endoscopes market is anticipated to grow at a CAGR of 4.93% from 2024 to 2032.
Ans: The market is expected to reach USD 36.93 billion by 2032, increasing from USD 24.00 billion in 2023.
Ans: Rising prevalence of gastrointestinal (GI) disorders, colorectal cancer, and respiratory diseases, increasing the demand for minimally invasive procedures.
Ans: The high cost of endoscopic procedures and devices remains a significant restraint.
Ans: North America dominated the Endoscopes market.
Table of content
1. Introduction
1.1 Market Definition
1.2 Scope (Inclusion and Exclusions)
1.3 Research Assumptions
2. Executive Summary
2.1 Market Overview
2.2 Regional Synopsis
2.3 Competitive Summary
3. Research Methodology
3.1 Top-Down Approach
3.2 Bottom-up Approach
3.3. Data Validation
3.4 Primary Interviews
4. Market Dynamics Impact Analysis
4.1 Market Driving Factors Analysis
4.1.2 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
4.2 PESTLE Analysis
4.3 Porter’s Five Forces Model
5. Statistical Insights and Trends Reporting
5.1 Incidence and Prevalence of Diseases Requiring Endoscopy (2023)
5.2 Endoscope Usage Trends by Product and Specialty (2023)
5.3 Healthcare Spending on Endoscopy Procedures, by Region and Payer Type (2023)
5.4 Technological Advancements and Adoption Trends in Endoscopy (2023-2032)
6. Competitive Landscape
6.1 List of Major Companies, By Region
6.2 Market Share Analysis, By Region
6.3 Service Benchmarking
6.3.1 Service specifications and features
6.3.2 Pricing
6.4 Strategic Initiatives
6.4.1 Marketing and promotional activities
6.4.2 Distribution and Supply Chain Strategies
6.4.3 Expansion plans and new Service launches
6.4.4 Strategic partnerships and collaborations
6.5 Technological Advancements
6.6 Market Positioning and Branding
7. Endoscopes Market Segmentation, by Product
7.2 Endoscopes
7.2.1 Endoscopes Market Trends Analysis (2020-2032)
7.2.2 Endoscopes Market Size Estimates and Forecasts to 2032 (USD Billion)
7.2.3 Reusable Endoscopes
7.2.3.1 Reusable Endoscopes Market Trends Analysis (2020-2032)
7.2.3.2 Reusable Endoscopes Market Size Estimates and Forecasts to 2032 (USD Billion)
7.2.4 Disposable Endoscopes
7.2.4.1 Disposable Endoscopes Market Trends Analysis (2020-2032)
7.2.4.2 Disposable Endoscopes Market Size Estimates and Forecasts to 2032 (USD Billion)
8. Endoscopes Market Segmentation, by End-use
8.2 Hospitals
8.2.1 Hospitals Market Trends Analysis (2020-2032)
8.2.2 Hospitals Market Size Estimates and Forecasts to 2032 (USD Billion)
8.3 Outpatient Facilities
8.3.1 Outpatient Facilities Market Trends Analysis (2020-2032)
8.3.2 Outpatient Facilities Market Size Estimates and Forecasts to 2032 (USD Billion)
9. Regional Analysis
9.1 Chapter Overview
9.2 North America
9.2.1 Trends Analysis
9.2.2 North America Endoscopes Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.2.3 North America Endoscopes Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.2.4 North America Endoscopes Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
9.2.5 USA
9.2.5.1 USA Endoscopes Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.2.5.2 USA Endoscopes Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
9.2.6 Canada
9.2.6.1 Canada Endoscopes Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.2.6.2 Canada Endoscopes Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
9.2.7 Mexico
9.2.7.1 Mexico Endoscopes Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.2.7.2 Mexico Endoscopes Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
9.3 Europe
9.3.1 Eastern Europe
9.3.1.1 Trends Analysis
9.3.1.2 Eastern Europe Endoscopes Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.3.1.3 Eastern Europe Endoscopes Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.3.1.4 Eastern Europe Endoscopes Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
9.3.1.5 Poland
9.3.1.5.1 Poland Endoscopes Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.3.1.5.2 Poland Endoscopes Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
9.3.1.6 Romania
9.3.1.6.1 Romania Endoscopes Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.3.1.6.2 Romania Endoscopes Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
9.3.1.7 Hungary
9.3.1.7.1 Hungary Endoscopes Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.3.1.7.2 Hungary Endoscopes Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
9.3.1.8 Turkey
9.3.1.8.1 Turkey Endoscopes Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.3.1.8.2 Turkey Endoscopes Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
9.3.1.9 Rest of Eastern Europe
9.3.1.9.1 Rest of Eastern Europe Endoscopes Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.3.1.9.2 Rest of Eastern Europe Endoscopes Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
9.3.2 Western Europe
9.3.2.1 Trends Analysis
9.3.2.2 Western Europe Endoscopes Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.3.2.3 Western Europe Endoscopes Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.3.2.4 Western Europe Endoscopes Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
9.3.2.5 Germany
9.3.2.5.1 Germany Endoscopes Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.3.2.5.2 Germany Endoscopes Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
9.3.2.6 France
9.3.2.6.1 France Endoscopes Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.3.2.6.2 France Endoscopes Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
9.3.2.7 UK
9.3.2.7.1 UK Endoscopes Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.3.2.7.2 UK Endoscopes Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
9.3.2.8 Italy
9.3.2.8.1 Italy Endoscopes Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.3.2.8.2 Italy Endoscopes Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
9.3.2.9 Spain
9.3.2.9.1 Spain Endoscopes Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.3.2.9.2 Spain Endoscopes Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
9.3.2.10 Netherlands
9.3.2.10.1 Netherlands Endoscopes Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.3.2.10.2 Netherlands Endoscopes Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
9.3.2.11 Switzerland
9.3.2.11.1 Switzerland Endoscopes Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.3.2.11.2 Switzerland Endoscopes Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
9.3.2.12 Austria
9.3.2.12.1 Austria Endoscopes Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.3.2.12.2 Austria Endoscopes Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
9.3.2.13 Rest of Western Europe
9.3.2.13.1 Rest of Western Europe Endoscopes Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.3.2.13.2 Rest of Western Europe Endoscopes Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
9.4 Asia Pacific
9.4.1 Trends Analysis
9.4.2 Asia Pacific Endoscopes Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.4.3 Asia Pacific Endoscopes Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.4.4 Asia Pacific Endoscopes Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
9.4.5 China
9.4.5.1 China Endoscopes Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.4.5.2 China Endoscopes Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
9.4.6 India
9.4.5.1 India Endoscopes Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.4.5.2 India Endoscopes Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
9.4.5 Japan
9.4.5.1 Japan Endoscopes Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.4.5.2 Japan Endoscopes Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
9.4.6 South Korea
9.4.6.1 South Korea Endoscopes Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.4.6.2 South Korea Endoscopes Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
9.4.7 Vietnam
9.4.7.1 Vietnam Endoscopes Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.2.7.2 Vietnam Endoscopes Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
9.4.8 Singapore
9.4.8.1 Singapore Endoscopes Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.4.8.2 Singapore Endoscopes Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
9.4.9 Australia
9.4.9.1 Australia Endoscopes Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.4.9.2 Australia Endoscopes Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
9.4.10 Rest of Asia Pacific
9.4.10.1 Rest of Asia Pacific Endoscopes Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.4.10.2 Rest of Asia Pacific Endoscopes Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
9.5 Middle East and Africa
9.5.1 Middle East
9.5.1.1 Trends Analysis
9.5.1.2 Middle East Endoscopes Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.5.1.3 Middle East Endoscopes Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.5.1.4 Middle East Endoscopes Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
9.5.1.5 UAE
9.5.1.5.1 UAE Endoscopes Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.5.1.5.2 UAE Endoscopes Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
9.5.1.6 Egypt
9.5.1.6.1 Egypt Endoscopes Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.5.1.6.2 Egypt Endoscopes Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
9.5.1.7 Saudi Arabia
9.5.1.7.1 Saudi Arabia Endoscopes Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.5.1.7.2 Saudi Arabia Endoscopes Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
9.5.1.8 Qatar
9.5.1.8.1 Qatar Endoscopes Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.5.1.8.2 Qatar Endoscopes Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
9.5.1.9 Rest of Middle East
9.5.1.9.1 Rest of Middle East Endoscopes Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.5.1.9.2 Rest of Middle East Endoscopes Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
9.5.2 Africa
9.5.2.1 Trends Analysis
9.5.2.2 Africa Endoscopes Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.5.2.3 Africa Endoscopes Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.5.2.4 Africa Endoscopes Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
9.5.2.5 South Africa
9.5.2.5.1 South Africa Endoscopes Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.5.2.5.2 South Africa Endoscopes Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
9.5.2.6 Nigeria
9.5.2.6.1 Nigeria Endoscopes Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.5.2.6.2 Nigeria Endoscopes Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
9.6 Latin America
9.6.1 Trends Analysis
9.6.2 Latin America Endoscopes Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.6.3 Latin America Endoscopes Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.6.4 Latin America Endoscopes Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
9.6.5 Brazil
9.6.5.1 Brazil Endoscopes Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.6.5.2 Brazil Endoscopes Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
9.6.6 Argentina
9.6.6.1 Argentina Endoscopes Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.6.6.2 Argentina Endoscopes Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
9.6.7 Colombia
9.6.7.1 Colombia Endoscopes Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.6.7.2 Colombia Endoscopes Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
9.6.8 Rest of Latin America
9.6.8.1 Rest of Latin America Endoscopes Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.6.8.2 Rest of Latin America Endoscopes Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
10. Company Profiles
10.1 Olympus Corporation
10.1.1 Company Overview
10.1.2 Financial
10.1.3 Products/ Services Offered
10.1.4 SWOT Analysis
10.2 Boston Scientific Corporation
10.2.1 Company Overview
10.2.2 Financial
10.2.3 Products/ Services Offered
10.2.4 SWOT Analysis
10.3 PENTAX Medical (Hoya Corporation)
10.3.1 Company Overview
10.3.2 Financial
10.3.3 Products/ Services Offered
10.3.4 SWOT Analysis
10.4 FUJIFILM Holdings Corporation
10.4.1 Company Overview
10.4.2 Financial
10.4.3 Products/ Services Offered
10.4.4 SWOT Analysis
10.5 KARL STORZ SE & Co. KG
10.5.1 Company Overview
10.5.2 Financial
10.5.3 Products/ Services Offered
10.5.4 SWOT Analysis
10.6 Stryker
10.6.1 Company Overview
10.6.2 Financial
10.6.3 Products/ Services Offered
10.6.4 SWOT Analysis
10.7 Medtronic
10.7.1 Company Overview
10.7.2 Financial
10.7.3 Products/ Services Offered
10.7.4 SWOT Analysis
10.8 Ambu A/S
10.8.1 Company Overview
10.8.2 Financial
10.8.3 Products/ Services Offered
10.8.4 SWOT Analysis
10.9 STERIS plc
10.9.1 Company Overview
10.9.2 Financial
10.9.3 Products/ Services Offered
10.9.4 SWOT Analysis
10.10 Richard Wolf GmbH
10.10.1 Company Overview
10.10.2 Financial
10.10.3 Products/ Services Offered
10.10.4 SWOT Analysis
11. Use Cases and Best Practices
12. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
Key Segments
By Product
Endoscopes
Reusable Endoscopes
Disposable Endoscopes
By End Use
Hospitals
Outpatient Facilities
Request for Segment Customization as per your Business Requirement: Segment Customization Request
Regional Coverage:
North America
US
Canada
Mexico
Europe
Eastern Europe
Poland
Romania
Hungary
Turkey
Rest of Eastern Europe
Western Europe
Germany
France
UK
Italy
Spain
Netherlands
Switzerland
Austria
Rest of Western Europe
Asia Pacific
China
India
Japan
South Korea
Vietnam
Singapore
Australia
Rest of Asia Pacific
Middle East & Africa
Middle East
UAE
Egypt
Saudi Arabia
Qatar
Rest of Middle East
Africa
Nigeria
South Africa
Rest of Africa
Latin America
Brazil
Argentina
Colombia
Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
Detailed Volume Analysis
Criss-Cross segment analysis (e.g. Product X Application)
Competitive Product Benchmarking
Geographic Analysis
Additional countries in any of the regions
Customized Data Representation
Detailed analysis and profiling of additional market players
The global tinnitus management market, valued at USD 3.45 Billion in 2023, is projected to reach USD 5.02 Billion by 2032, growing at a compound annual growth rate CAGR of 4.44% during the forecast period.
Liver Disease Diagnostics Market was valued at USD 35.97 billion in 2023 and is expected to reach USD 64.23 billion by 2032, growing at a CAGR of 6.69% from 2024-2032.
The Covered Stent Market size was valued at USD 1.90 billion in 2023 and is expected to reach USD 2.69 billion by 2032 and grow at a CAGR of 3.96% over the forecast period 2024-2032.
The Point of Care Lipid Test Market size was estimated USD 305.53 million in 2023 and is expected to reach USD 444.36 million by 2032 at a CAGR of 4.25% during the forecast period of 2024-2032.
The Dermatology Drugs Market was valued at USD 20.34 billion in 2023 and is expected to reach USD 51.14 billion by 2032, growing at a CAGR of 10.71% from 2024-2032.
The Orthobiologics Market was valued USD 7.15 billion in 2023 anticipated to grow USD 11.59 billion by 2032 with compound annual growth rate of 5.55% over the forecast period 2024-2032.
Hi! Click one of our member below to chat on Phone
© 2025 All Rights Reserved by SNS Insider Pvt Ltd
